Literature DB >> 20831499

Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients.

Marianne Marquard Knap1, Lone Hoffmann, Marianne Nordsmark, Anne Vestergaard.   

Abstract

PURPOSE/
OBJECTIVE: Daily Cone-beam computed tomography (CBCT) in room imaging is used to determine tumour shrinkage during a full radiotherapy (RT) course. In addition, relative interfractional tumour and lymph node motion is determined for each RT fraction.
MATERIAL AND METHODS: From November 2009 to March 2010, 20 consecutive lung cancer patients (14 NSCLC, 6 SCLC) were followed with daily CBCT during RT. The gross tumour volume for lung tumour (GTV-t) was visible in all daily CBCT scans and was delineated at the beginning, at the tenth and the 20th fraction, and at the end of treatment. Whenever visible, the gross tumour volume for lymph nodes (GTV-n) was also delineated. The GTV-t and GTV-n volumes were determined. All patients were setup according to an online bony anatomy match. Retrospectively, matching based on the internal target volume (ITV), the GTV-t or the GTV-n was performed.
RESULTS: In eight patients, we observed a significant GTV-t shrinkage (15-40%) from the planning CT until the last CBCT. Only five patients presented a significant shrinkage (21-37%) in the GTV-n. Using the daily CBCT imaging, it was found that the mean value of the difference between a setup using the skin tattoo and an online matching using the ITV was 7.3±2.9 mm (3D vector in the direction of ITV). The mean difference between the ITV and bony anatomy matching was 3.0±1.3 mm. Finally, the mean distance between the GTV-t and the GTV-N was 2.9±1.6 mm.
CONCLUSION: One third of all patients with lung cancer undergoing chemo-RT achieved significant tumour shrinkage from planning CT until the end of the radiotherapy. Differences in GTV-t and GTV-n motion was observed and matching using the ITV including both GTV-t and GTV-n is therefore preferable.

Entities:  

Mesh:

Year:  2010        PMID: 20831499     DOI: 10.3109/0284186X.2010.498434

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  17 in total

1.  Localization accuracy from automatic and semi-automatic rigid registration of locally-advanced lung cancer targets during image-guided radiation therapy.

Authors:  Scott P Robertson; Elisabeth Weiss; Geoffrey D Hugo
Journal:  Med Phys       Date:  2012-01       Impact factor: 4.071

Review 2.  Recent advances in radiotherapy for thoracic tumours.

Authors:  Michael Fay; Christopher M Poole; Gary Pratt
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

3.  Assessment of the robustness of volumetric-modulated arc therapy for lung radiotherapy.

Authors:  K Edmunds; J Bedford
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

4.  Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.

Authors:  Khaled Elsayad; Jan Kriz; Gabriele Reinartz; Sergiu Scobioala; Iris Ernst; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2015-12-02       Impact factor: 3.621

5.  Investigation of the use of external aluminium targets for portal imaging in a medical accelerator using Geant4 Monte Carlo simulation.

Authors:  Hyungdong Kim; Byungyong Kim; Jonggeun Baek; Youngkee Oh; Sangmo Yun; Hyunsoo Jang
Journal:  Br J Radiol       Date:  2018-02-06       Impact factor: 3.039

Review 6.  Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer.

Authors:  Jason K Molitoris; Tejan Diwanji; James W Snider; Sina Mossahebi; Santanu Samanta; Shahed N Badiyan; Charles B Simone; Pranshu Mohindra
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 7.  Image-guided radiotherapy and motion management in lung cancer.

Authors:  S S Korreman
Journal:  Br J Radiol       Date:  2015-05-08       Impact factor: 3.039

8.  The importance of image guided radiotherapy in small cell lung cancer: Case report and review of literature.

Authors:  Francisco Javier Lozano Ruiz; Sandra Ileana Pérez Álvarez; María Adela Poitevin Chacón; Federico Maldonado Magos; Rubi Ramos Prudencio; Luis Cabrera Miranda; Oscar Arrieta
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-20

9.  Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer.

Authors:  Junjie Miao; Hui Yan; Yuan Tian; Pan Ma; Zhiqiang Liu; Minghui Li; Wenting Ren; Jiayun Chen; Ye Zhang; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2017-10-11       Impact factor: 2.102

10.  A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer.

Authors:  Chenxue Jiang; Shuiyun Han; Wucheng Chen; Xiaozhen Ying; He Wu; Yaoyao Zhu; Guodong Shi; Xiaojiang Sun; Yaping Xu
Journal:  Oncotarget       Date:  2018-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.